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ABSTRACT. Australian Aboriginals are overrepresented in prisons
and tend to be overrepresented in studies of injecting drug users (IDU).
The aim of this study was to examine differences between Aboriginal
and non-Aboriginal IDUs in terms of gender, prison history and hepatitis
C status and testing. Secondary analyses were conducted on data from
three cross-sectional studies of IDUs. These studies employed similar
methodologies, with recruitment being through needle and syringe pro-
grams, methadone clinics, snowballing and street intercepts. All studies
were coordinated through the National Drug and Alcohol Research Cen-
tre. Aboriginal people were overrepresented in all studies, were more
likely to have been incarcerated and to report heroin as their drug of
choice than non-Aboriginal IDUs. Females tended to be overrepresented
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among Aboriginal IDUs, were more likely to have been incarcerated and
had a longer period of time since their last hepatitis C test than non-Ab-
original female IDUs. Aboriginal people are overrepresented among
IDUs in Sydney. Given their greater risk of incarceration, particularly
among females, Aboriginal IDUs were at greater risk of hepatitis C ex-
posure than non-Aboriginal IDUs. The prison setting provides an oppor-
tunity to promote drug treatment and hepatitis C testing, though more
needs to be done to reduce drug use and incarceration. [Article copies
available for a fee from The Haworth Document Delivery Service: 1-800-
HAWORTH. E-mail address: <docdelivery@haworthpress.com> Website: <http://
www.HaworthPress.com> © 2003 by The Haworth Press, Inc. All rights reserved.]
KEYWORDS. Australian Aboriginals, injecting drug use, prison, drug
treatment and hepatitis C testing
Australian Aboriginals make up approximately 2% of the Australian
population, yet constitute 15% of the national prison population (Aus-
tralian Bureau of Statistics, 1998, 2002). In New South Wales (NSW)
prisons, 19% of female inmates were of Aboriginal or Torres Strait Is-
lander descent compared to 14% of male inmates (Corben, 2001).
Injecting drug users (IDUs) are also overrepresented in prison popu-
lations. A study of prison entrants in the state of Victoria found that
46% of the sample reported a history of injecting drug use, many of
whom injected drugs while in prison (Crofts et al., 1995). The NSW In-
mate Health Survey found that 32% of females and 21% of males had
injected drugs in prison at some time (Butler, 1997).
Given the unknown parameters of the IDU population, it is difficult
to know the prevalence of injecting drug use among Aboriginal and
non-Aboriginal groups. The National Drug Strategy Household Survey
found that the prevalence of heroin, cocaine and amphetamine use was
similar among Aboriginal and non-Aboriginal populations (Common-
wealth Department of Health and Aged Care, 1994), though household
surveys are likely to underestimate illicit drug use (Hall, Ross, Lynskey,
Law, & Degenhardt, 2000). Furthermore, the extent of injecting drug
use is likely to differ between jurisdictions and communities. One study
reported significantly different levels of lifetime heroin use among Ab-
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original communities living in two small urban communities in NSW
(12% vs. 1%) (Perkins et al., 1994). Aggregated lifetime prevalence of
heroin use for the two communities was higher in the Aboriginal popu-
lation when compared to the general population (6% and 2%) (Perkins
et al., 1994).
In the National needle and syringe program survey, 5% of the sample
were Aboriginal, further indicating that Aboriginal people are over-
represented among IDU populations (MacDonald et al., 1997). This
trend has been even more evident in Sydney: in the Australian Study of
HIV and Injecting Drug Use, 13% of the Sydney sample were Aborigi-
nal, compared to 5% of the national sample, despite similar recruitment
methods (Loxley, Carruthers, & Bevan, 1995; Rutter, Dolan, & Wodak,
1996).
Despite a burgeoning body of literature on alcohol and other drug prob-
lems among Aboriginal people (for a review see Gracey, 1998), a review
of Australian illicit drug research found that there has been little re-
search into Aboriginal injecting drug use (Hando, Hall, Rutter, & Dolan,
1998). With secondary analyses of existing databases, the current study
examined differences between Aboriginal and non-Aboriginal IDUs in
terms of gender, prison history, hepatitis C virus antibody (HCV) test-
ing and drug treatment history.
METHODS
Studies completed by the National Drug and Alcohol Research Cen-
tre (NDARC) since 1997, which targeted IDUs and contained informa-
tion on Aboriginal and Torres Straight Islander status, were selected.
Data for three cross-sectional studies of IDUs recruited in Sydney were
available for review: The Illicit Drug Reporting System (IDRS), the
Australian Prevalence and Estimate of Treatment Study (APET) and
the Australian Blood-borne virus Risk and Injecting Drug Use Study
(ABRIDUS). The IDRS involved a cross-sectional study repeated over
four years (1997-2000). These studies were aggregated into one data
set. APET data were collected from October 2000 to March 2001 and
ABRIDUS data were collected in 1999.
All studies targeted similar populations and used similar entry crite-
ria. Participants were either current IDUs (any drug), heroin users or on
a methadone maintenance program. Aboriginal IDUs were not specifi-
cally targeted and participation was voluntary.
Day, Ross, and Dolan 53
D
ow
nl
oa
de
d 
by
 [U
niv
ers
ity
 of
 W
es
ter
n O
nta
rio
] a
t 1
3:1
4 2
5 O
cto
be
r 2
01
2 
In each study participants were recruited through a variety of meth-
ods, including needle and syringe programs and methadone clinics, or
via street intercept and snowballing (word of mouth). Interviews were
conducted face-to-face by trained interviewers using structured ques-
tionnaires. Participants were reimbursed $20 or $30 for travel expenses.
All studies collected information on demographics, main drug used,
needle and syringe sharing and prison history. APET and ABRIDUS
collected information on self-reported HCV status and drug treatment
history. APET also collected information on HCV testing.
RESULTS
Aboriginal people were overrepresented in all three studies, consti-
tuting 15-19% of the samples (Table 1). Characteristics of Aboriginal
and non-Aboriginal IDU are shown in Table 2. There were more female
Aboriginal IDU than non-Aboriginal IDU in APET (56% vs. 33%, 2 =
12.62, 1 df, p < 0.001).
Lifetime prevalence of incarceration was higher in the Aboriginal
sample than the non-Aboriginal sample in the IDRS (68% vs. 49%, 2 =
13.72, 1 df, p < 0.001).
More Aboriginal IDUs reported heroin as their main drug than
non-Aboriginal IDUs, in APET (87% vs. 76%, 2 = 4.32, 1 df, p < 0.05).
Similar proportions of Aboriginal and non-Aboriginal IDUs reported
using a needle or syringe after another person in the last month. Aborig-
inal and non-Aboriginal IDUs were similar in all other areas investi-
gated (Table 2).
Female IDUs
There were 441 female IDUs in the three studies, representing 24%
of participants in all studies. More Aboriginal females reported a his-
tory of incarceration than non-Aboriginal females in the IDRS (68% vs.
54 JOURNAL OF ETHNICITY IN SUBSTANCE ABUSE
TABLE 1. Percent of Aboriginal IDU in Each Study
Study Year of Data Collection n % Aboriginal
APET 2000-2001 399 17
IDRS 1997-2000 636 19
ABRIDUS 1999 150 15
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49%, 2 = 6.61, 1 df, p < 0.01) and ABRIDUS (68% vs. 51%, Fisher’s
exact test, p < 0.01).
There were no significant differences in terms of self-reported HCV
status between the Aboriginal and non-Aboriginal females or in receiv-
ing pre- and post-test counselling. However, Aboriginal females were
significantly more likely to report a longer period of time since their last
HCV test (45 vs. 25 weeks, t137 = 2.58, p < 0.01).
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TABLE 2. Characteristics of Aboriginal and Non-Aboriginal IDU
Variable Aboriginal Non-Aboriginal
Mean Age (SD)
APET 33 (6.7) 31 (8.2)
IDRS 30 (7.1) 29 (7.9)
ABRIDUS 29 (7.9) 30 (7.8)
% Female
APET* 59 33
IDRS 39 35
ABRIDUS 45 38
% Ever been in prison
APET 54 39
IDRS* 68 49
ABRIDUS 68 51
% Used a syringe after another
person in past month
APET 7 9
IDRS 10 18
ABRIDUS 24 26
% HCV positive (self reported)
APET 59 59
ABRIDUS 67 64
% Main drug heroin
APET** 87 76
IDRS 85 78
ABRIDUS 77 69
% History of treatment for heroin
dependence
APET 59 59
ABRIDUS 67 64
% Ever experienced a barrier
to treatment for heroin use
APET 38 40
*p < 0.001, **p < 0.05
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In APET more Aboriginal females reported heroin as their main drug
compared to non-Aboriginal females (90% vs. 72%, Fisher’s exact test, p <
.05). Similar proportions of Aboriginal and non-Aboriginal females re-
ported ever having been in drug treatment in both APET (82% and 87%,
respectively) and ABRIDUS (80% and 56%).
DISCUSSION
To date there has been little research into injecting drug use among
Aboriginal people and little is currently known about this group (Hando
et al., 1998). This study, however, has found that Aboriginal people
were overrepresented among samples of IDUs in Sydney. Compared to
non-Aboriginal IDUs, Aboriginal IDUs were more likely to have been
imprisoned. The study has also found that Aboriginal females were over-
represented in samples of IDUs relative to non-Aboriginal females, and
that these Aboriginal females were significantly more likely to have a
history of incarceration. Both of these factors suggest that Aboriginal
IDUs and their communities are at a double disadvantage in terms of
blood-borne viral risk.
The overrepresentation of Aboriginal people in Australian prisons
has been well documented, as has the overrepresentation of IDUs (But-
ler et al., 1997; Crofts et al., 1995; Royal Commission into Aboriginal
Deaths in Custody, 1991). The prevalence of HCV among Australian pris-
oners is also high (Butler et al., 1997; Crofts et al., 1995) and despite
limited research, transmission is also likely to be high (Dolan, 2001).
Aboriginal people who inject drugs were more likely to report a history
of incarceration than their non-Aboriginal peers, placing them and their
communities at higher risk of blood-borne viral infections than other
IDUs.
Some reasons given for the elevated levels of incarceration of Ab-
original people generally include issues around racism, colonisation,
and the dispossession of land and culture oppression (Lincoln & Wil-
son, 1994). The added problems of dependency and the pressure and
stigma of illicit drug use may further compound the problem.
Females typically account for approximately a third of the IDU pop-
ulation (Loxley et al., 1995; MacDonald et al., 1997). Yet, this study
found that Aboriginal females constitute closer to 50% of Aboriginal
IDUs and that they were more likely to have been incarcerated than
non-Aboriginal female IDUs. Females who inject drugs are disadvan-
taged in a range of areas, including syringe sharing and treatment op-
56 JOURNAL OF ETHNICITY IN SUBSTANCE ABUSE
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tions (Whynot, 1998). The prevalence of HCV is also higher among
female prisoners compared to male prisoners (Butler et al., 1997; Crofts
et al., 1995). These three factors taken together indicate greater HCV
risk for Aboriginal female IDUs compared to non-Aboriginal female
IDUs.
Aboriginal females were less likely to have reported being recently
tested for HCV than the non-Aboriginal females, indicating that HCV
may be higher than reported. As demonstrated with HIV, pre- and
post-test counselling can reduce risk behaviour (Gibson, McCusker, &
Chesney, 1998). That large proportions of IDUs had not received coun-
selling (or do not remember anything of the process) is of concern and
has implications in terms of the prevention of blood-borne viral trans-
mission and requires further investigation.
There are a number of limitations of this study. The data presented
here were from three different studies with different aims and therefore
instruments. However, all three studies were conducted by the same
Centre and similar methodologies were employed. The small numbers
of participants in each study may have compromised statistical power
and therefore the number of firm conclusions that can be made.
Nonetheless, the data from this study have suggested that Aboriginal
people were overrepresented among IDUs, particularly females, and are
therefore at increased risk of HCV and other blood-borne infections.
Given the high prevalence of incarceration reported by Aboriginal
IDUs, the prison setting provides an opportunity to promote drug treat-
ment and blood-borne virus testing. However, more needs to be done to
reduce the numbers of both Aboriginal people and IDUs entering prison.
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